This inventor holds 5 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Incyte Corporation. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2026
Title: Peng Zhao: Innovator in Pharmaceutical Compounds
Introduction
Peng Zhao is a notable inventor based in Newark, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological activities. With a total of 5 patents to his name, Zhao's work is paving the way for advancements in cancer treatment.
Latest Patents
Among his latest patents, Zhao has developed "Pyrazolopyrimidine compounds and uses thereof." This invention discloses compounds of Formula (I) and methods for using these compounds to inhibit ALK2 activity and/or FGFR activity. The pharmaceutical compositions comprising these compounds are particularly useful in treating, preventing, or ameliorating diseases associated with ALK2 and FGFR activity, including various forms of cancer. Another significant patent is focused on "Bicyclic heterocycles as FGFR inhibitors." This invention relates to bicyclic heterocycles and their pharmaceutical compositions, which serve as inhibitors of the FGFR enzyme, offering potential treatments for FGFR-associated diseases such as cancer.
Career Highlights
Peng Zhao is currently associated with Incyte Corporation, a leading biopharmaceutical company. His work at Incyte has allowed him to focus on innovative research and development in the pharmaceutical sector. Zhao's expertise in creating compounds that target specific pathways in cancer biology has positioned him as a key player in the industry.
Collaborations
Zhao has collaborated with talented individuals such as Oleg Vechorkin and Minh Nguyen. These collaborations have fostered a productive environment for innovation and have contributed to the success of their research endeavors.
Conclusion
Peng Zhao's contributions to pharmaceutical innovations are noteworthy, particularly in the realm of cancer treatment. His patents reflect a commitment to advancing medical science and improving patient outcomes. The impact of his work will likely resonate in the field for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile